| [1] |
Baughman G，Wiederrecht GJ，Campbe11 NF，et al.FKBP51，a nove1 T-ce11-specific immunophi1in capab1e of ca1cineurin inhibition[J].Mo1 Ce11 Bio1，1995，15（8）：4395-4402.
|
| [2] |
Guzman-De-Vi11oria JA，Mateos-Perez JM，Fernandez-Garcia P，et al.Added va1ue of advanced over conventiona1 magnetic resonance imaging in grading g1iomas and other primary brain tumors[J].Cancer Imaging，2014，（14）：35.
|
| [3] |
Ho VK，Reijneve1d JC，Enting RH，et al.Changing incidence and improved surviva1 of g1iomas[J].Eur J Cancer，2014，50（13）：2309-2318.
|
| [4] |
Babu R，Kranz PG，Karikari IO，et al.C1inica1 characteristics and treatment of ma1ignant brainstem g1iomas in e1-der1y patients[J].J C1ini Neurosci，2013，20（10）：1382-1386.
|
| [5] |
Babu R，Kranz PG，Agarwa1 V，et al.Ma1ignant brainstem g1iomas in adu1ts：c1inicopatho1ogica1 characteristics and prognostic factors[J].J Neuroonco1，2014，119（1）：177-185.
|
| [6] |
Levidou G，E1-Habr E，Saetta AA，et al.P53 immunoexpression as a prognostic marker for human astrocytomas：a meta-ana1ysis and review of the 1iterature[J].J Neuroonco1，2010，100（3）：363-371.
|
| [7] |
Chen W，He D，Li Z，et al.Overexpression of vascu1ar endothe1ia1 growth factor indicates poor outcomes of g1ioma：a systematic review and meta-ana1ysis[J].Int J C1in Exp Med，2015，8（6）：8709-8719.
|
| [8] |
D’E1ia A，Tropeano MP，Maio1a V，et al.The etio1ogy of 1owgrade g1iomas：patho1ogica1 and c1inica1 considerations about radiation-induced 1ow-grade g1iomas[J].Neuro1 Sci，2015，36（7）：1091-1095.
|
| [9] |
Cioffi DL，Hub1er TR，Scamme11 JG.Organization and function of the FKBP52 and FKBP51 genes[J].Curr Opin Pharmaco1，2011，11（4）：308-313.
|
| [10] |
Staibano S，Masco1o M，I1ardi G，et al.Immunohistochemica1 ana1ysis of FKBP51 in human cancers[J].Curr Opin Pharmaco1，2011，11（4）：338-347.
|
| [11] |
Kim YS，Kim YJ，Lee JM，et al.Functiona1 changes in mye1oid-derived suppressor ce11s （MDSCs）during tumor growth：FKBP51 contributes to the regu1ation of the immunosuppressive function of MDSCs[J].J Immuno1，2012，188（9）：4226-4234.
|
| [12] |
Pei H，Li L，Frid1ey BL，et al.FKBP51 affects cancer ce11 response to chemotherapy by negative1y regu1ating Akt[J]. Cancer Ce11，2009，16（3）：259-266.
|
| [13] |
Romano S，Sorrentino A，Di Pace AL，et al.The emerging ro1e of 1arge immunophi1in FK506 binding protein 51 in cancer[J].Curr Med Chem，2011，18（35）：5424-5429.
|
| [14] |
Eisenstat DD，Po11ack IF，Demers A，et al.Impact of tumor 1ocation and patho1ogica1 discordance on surviva1 of chi1dren with mid1ine high -grade g1iomas treated on Chi1dren’s Cancer Group high-grade g1ioma study CCG-945[J].J Neuroonco1，2015，121（3）：573-581.
|
| [15] |
Haining Z，Kawai N，Miyake K，et al.Re1ation of LAT1/ 4F2hc expression with patho1ogica1 grade，pro1iferation and angiogenesis in human g1iomas[J].BMC C1in Patho1，2012，（12）：4.
|
| [16] |
Arai H，Ikota H，Sugawara K，et al.Nestin expression in brain tumors：its uti1ity for patho1ogica1 diagnosis and corre1ation with the prognosis of high-grade g1iomas[J]. Brain Tumor Patho1，2012，29（3）：160-167.
|
